Walle T, Conradi E C, Walle U K, Gaffney T E
Drug Metab Dispos. 1978 Jul-Aug;6(4):481-7.
Two isomeric methoxyhydroxy metabolites of propranolol have been identified in man during chronic antihypertensive propranolol therapy. The identification was based on the mass-spectral fragmentation pattern of their trifluoroacetylated derivatives. Both isomers were detected in urine as well as in plasma, mainly as glucuronic acid and/or sulfate conjugates. The amounts of these metabolites excreted in urine were linearly related (r = 0.84) to the oral propranolol dose, 10--320 mg per day. Plasma concentrations at the 320-mg daily dose ranged from 20 to 112 ng/ml. Similar isomeric methoxyhydroxy metabolites of propranolol containing a glycol or a lactic acid side-chain were also identified.
在慢性降压普萘洛尔治疗期间,人体中已鉴定出普萘洛尔的两种异构甲氧基羟基代谢物。该鉴定基于其三氟乙酰化衍生物的质谱裂解模式。两种异构体在尿液和血浆中均被检测到,主要以葡萄糖醛酸和/或硫酸盐结合物的形式存在。这些代谢物在尿液中的排泄量与口服普萘洛尔剂量(每天10 - 320毫克)呈线性相关(r = 0.84)。每日320毫克剂量时的血浆浓度范围为20至112纳克/毫升。还鉴定出了含有二醇或乳酸侧链的普萘洛尔类似异构甲氧基羟基代谢物。